Hacker News new | ask | show | jobs
by jibal 1 day ago
Sorry, it does not apply ... this drug inhibits (for the first time) the KRAS mutation (previously considered "undruggable") that is the primary cause of 90% of pancreatic cancers and 50% of colon cancers.
1 comments

No reason to be sorry, that sounds like this is even better news then :)
I just meant that this doesn't apply to lymphoma, which is not caused by KRAS.